1. Natural-product-inspired design and synthesis of two series of compounds active against Trypanosoma cruzi: Insights into structure-activity relationship, toxicity, and mechanism of action
- Author
-
Eloir Paulo Schenkel, Bibiana Paula Dambrós, Lílian Sibelle Campos Bernardes, Mário Steindel, Milene Höehr de Moraes, Florence Popowycz, Rafael da Rosa, Maïwenn Jacolot, Lucie Grand, Universidade Federal de Santa Catarina = Federal University of Santa Catarina [Florianópolis] (UFSC), Institut de Chimie et Biochimie Moléculaires et Supramoléculaires (ICBMS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), and Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut de Chimie du CNRS (INC)-École Supérieure Chimie Physique Électronique de Lyon-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Antiparasitic ,medicine.drug_class ,Trypanosoma cruzi ,01 natural sciences ,Biochemistry ,Lignans ,03 medical and health sciences ,chemistry.chemical_compound ,Structure-Activity Relationship ,Alkaloids ,Parasitic Sensitivity Tests ,Drug Discovery ,medicine ,Humans ,Isoxazole ,Furans ,Molecular Biology ,Oxazoles ,ComputingMilieux_MISCELLANEOUS ,030304 developmental biology ,Oxazole ,0303 health sciences ,Biological Products ,Natural product ,biology ,Dose-Response Relationship, Drug ,Molecular Structure ,010405 organic chemistry ,Chemistry ,[CHIM.ORGA]Chemical Sciences/Organic chemistry ,Organic Chemistry ,biology.organism_classification ,Trypanocidal Agents ,In vitro ,0104 chemical sciences ,Mechanism of action ,Benznidazole ,Drug Design ,medicine.symptom ,medicine.drug - Abstract
Chemical scaffolds of natural products have historically been sources of inspiration for the development of novel molecules of biological relevance, including hit and lead compounds. To identify new compounds active against Trypanosoma cruzi, we designed and synthesized 46 synthetic derivatives based on the structure of two classes of natural products: tetrahydrofuran lignans (Series 1) and oxazole alkaloids (Series 2). Compounds were screened in vitro using a cellular model of T. cruzi infection. In the first series of compounds, 11 derivatives of hit compound 5 (EC50 = 1.1 µM) were found to be active; the most potent (7, 8, and 13) had EC50 values of 5.1–34.2 µM. In the second series, 17 analogs were found active at 50 µM; the most potent compounds (47, 49, 59, and 63) showed EC50 values of 24.2–49.1 µM. Active compounds were assessed for selectivity, hemocompatibility, synergistic potential, effects on mitochondrial membrane potential, and inhibitory effect on trypanothione reductase. All active compounds showed low toxicity against uninfected THP-1 cells and human erythrocytes. The potency of compounds 5 and 8 increased steadily in combination with benznidazole, indicating a synergistic effect. Furthermore, compounds 8, 47, 49, 59, and 63 inhibited parasitic mitochondria in a dose-dependent manner. Although increased reactive oxygen species levels might be involved in the mitochondrial effects caused by compounds, the results indicate that the mechanism of action is not dependent on trypanothione reductase inhibition. In silico calculation of chemical descriptors and principal component analysis showed that the active compounds share common chemical features with other trypanocidal molecules and are predicted to have a good ADMET profile. Overall, the results suggest that the compounds are important candidates to be further studied for their potential against T. cruzi.
- Published
- 2021
- Full Text
- View/download PDF